ImmunityBio, Inc. (IBRX)
8.70
+0.09
(+1.05%)
USD |
NASDAQ |
Feb 20, 16:00
8.70
0.00 (0.00%)
Pre-Market: 20:00
ImmunityBio Total Assets (Quarterly) : 518.99M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novavax, Inc. | 1.180B |
| Krystal Biotech, Inc. | 1.334B |
| Rapt Therapeutics, Inc. | 165.74M |
| Moderna, Inc. | 12.34B |
| Corcept Therapeutics, Inc. | 823.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.042B |
| Shareholders Equity (Quarterly) | -524.32M |
| Debt to Equity Ratio | -1.643 |
| Current Ratio | 5.767 |
| Net Debt Paydown Yield | 1.14% |